Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 5.95% vs 9.71% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is -2.48% vs -2.11% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is -6.24% vs -41.17% in Mar 2025
Compare Balance Sheet Results of Krebs Biochem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
21.56
10.13
11.43
112.83%
Share Warrants & Outstandings
Total Reserve
-184.32
60.42
-244.74
-405.06%
Shareholder's Funds
-162.75
75.80
-238.55
-314.71%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
163.55
36.97
126.58
342.39%
Secured Loans
0.00
20.97
-20.97
-100.00%
Unsecured Loans
163.55
16.00
147.55
922.19%
Deferred Tax Assets / Liabilities
0.00
1.80
-1.80
-100.00%
Other Long Term Liabilities
45.00
0.00
45.00
0.00%
Long Term Trade Payables
1.61
0.00
1.61
0.00%
Long Term Provisions
2.78
0.72
2.06
286.11%
Total Non-Current Liabilities
212.94
39.49
173.45
439.23%
Current Liabilities
Trade Payables
13.76
34.71
-20.95
-60.36%
Other Current Liabilities
37.32
11.04
26.28
238.04%
Short Term Borrowings
61.29
39.39
21.90
55.60%
Short Term Provisions
0.70
0.00
0.70
0.00%
Total Current Liabilities
113.07
85.14
27.93
32.80%
Total Liabilities
163.25
200.43
-37.18
-18.55%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
314.01
49.49
264.52
534.49%
Less: Accumulated Depreciation
172.30
19.18
153.12
798.33%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
141.71
30.31
111.40
367.54%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.59
56.54
-54.95
-97.19%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
10.33
1.79
8.54
477.09%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
153.62
88.63
64.99
73.33%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
5.70
46.06
-40.36
-87.62%
Sundry Debtors
0.00
43.58
-43.58
-100.00%
Cash and Bank
0.13
14.51
-14.38
-99.10%
Other Current Assets
0.35
1.65
-1.30
-78.79%
Short Term Loans and Advances
3.43
5.99
-2.56
-42.74%
Total Current Assets
9.62
111.80
-102.18
-91.40%
Net Current Assets (Including Current Investments)
-103.44
26.65
-130.09
-488.14%
Total Current Assets Excluding Current Investments
9.62
111.80
-102.18
-91.40%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
163.25
200.43
-37.18
-18.55%
Contingent Liabilities
10.26
0.50
9.76
1,952.00%
Total Debt
224.84
76.36
148.48
194.45%
Book Value per share (adjusted)
-75.49
69.66
-145.15
-208.37%
Annual - Borrowings
Borrowings 224.84 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 5.95% vs 9.71% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 45.00 Cr
in Mar 2026Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 143.30 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -2.48% vs -2.11% in Mar 2025
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 9.62 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -6.24% vs -41.17% in Mar 2025